AWK vs CLDX · P/E 22, rev $4.65B vs rev $7.0M
American Water Works (AWK) versus Celldex Therapeutics Inc (CLDX) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Latest reported CLDX revenue for 2024-12-31 was $7.0M. Revenue was up 2.0% from 2023-12-31 to 2024-12-31. CLDX currently screens at market cap $2.35B.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. CLDX currently screens at market cap $2.35B.
Not investment advice. Open the AWK and CLDX stock pages for the full models.
Not investment advice.